Yao Shenggen, Zhang Min-Min, Yoshikami Doju, Azam Layla, Olivera Baldomero M, Bulaj Grzegorz, Norton Raymond S
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.
Biochemistry. 2008 Oct 14;47(41):10940-9. doi: 10.1021/bi801010u. Epub 2008 Sep 18.
mu-SIIIA, a novel mu-conotoxin from Conus striatus, appeared to be a selective blocker of tetrodotoxin-resistant sodium channels in frog preparations. It also exhibited potent analgesic activity in mice, although its selectivity profile against mammalian sodium channels remains unknown. We have determined the structure of mu-SIIIA in aqueous solution and characterized its backbone dynamics by NMR and its functional properties electrophysiologically. Consistent with the absence of hydroxyprolines, mu-SIIIA adopts a single conformation with all peptide bonds in the trans conformation. The C-terminal region contains a well-defined helix encompassing residues 11-16, while residues 3-5 in the N-terminal region form a helix-like turn resembling 3 10-helix. The Trp12 and His16 side chains are close together, as in the related conotoxin mu-SmIIIA, but Asn2 is more distant. Dynamics measurements show that the N-terminus and Ser9 have larger-magnitude motions on the subnanosecond time scale, while the C-terminus is more rigid. Cys4, Trp12, and Cys13 undergo significant conformational exchange on microsecond to millisecond time scales. mu-SIIIA is a potent, nearly irreversible blocker of Na V1.2 but also blocks Na V1.4 and Na V1.6 with submicromolar potency. The selectivity profile of mu-SIIIA, including poor activity against the cardiac sodium channel, Na V1.5, is similar to that of the closely related mu-KIIIA, suggesting that the C-terminal regions of both are critical for blocking neuronal Na V1.2. The structural and functional characterization described in this paper of an analgesic mu-conotoxin that targets neuronal subtypes of mammalian sodium channels provides a basis for the design of novel analogues with an improved selectivity profile.
μ-SIIIA是一种来自带纹芋螺的新型μ-芋螺毒素,在青蛙制剂中似乎是河豚毒素抗性钠通道的选择性阻滞剂。它在小鼠中也表现出强效镇痛活性,尽管其对哺乳动物钠通道的选择性概况尚不清楚。我们已经确定了μ-SIIIA在水溶液中的结构,并通过核磁共振表征了其主链动力学,以及通过电生理学表征了其功能特性。与缺乏羟脯氨酸一致,μ-SIIIA采用单一构象,所有肽键均处于反式构象。C端区域包含一个明确的螺旋,涵盖残基11-16,而N端区域的残基3-5形成一个类似螺旋的转角,类似于3-10螺旋。与相关的芋螺毒素μ-SmIIIA一样,Trp12和His16侧链靠得很近,但Asn2更远。动力学测量表明,N端和Ser9在亚纳秒时间尺度上具有更大幅度的运动,而C端更刚性。Cys4、Trp12和Cys13在微秒到毫秒时间尺度上经历显著的构象交换。μ-SIIIA是Na V1.2的强效、几乎不可逆的阻滞剂,但也以亚微摩尔效力阻断Na V1.4和Na V1.6。μ-SIIIA的选择性概况,包括对心脏钠通道Na V1.5的活性较差,与密切相关的μ-KIIIA相似,表明两者的C端区域对于阻断神经元Na V1.2至关重要。本文中描述的针对哺乳动物钠通道神经元亚型的镇痛μ-芋螺毒素的结构和功能表征为设计具有改进选择性概况的新型类似物提供了基础。